Applied Molecular Transport Inc. Common Stock
AMTI
AMTI was delisted on the 26th of December, 2023.
28 hedge funds and large institutions have $4.25M invested in Applied Molecular Transport Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 7 closing their positions.
20% less funds holding
Funds holding: 35 → 28 (-7)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less capital invested
Capital invested by funds: $6.39M → $4.25M (-$2.14M)
69% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 13
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.13K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$475 |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$262 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$121K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$40K |
| 3 |
Millennium Management
New York
|
-$38.4K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$26.7K |
| 5 |
BlackRock
New York
|
-$23.7K |
AMTI Hedge Fund Activity: Q2 2023 in Review
28 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Applied Molecular Transport Inc. Common Stock (AMTI) for Q2 2023, worth a combined $4.25M — down 34% from $6.39M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of AMTI and 0 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.13K. The largest seller was Morgan Stanley, cutting an estimated $121K.
- 28 institutional investors held Applied Molecular Transport Inc. Common Stock (AMTI) as of Q2 2023, down from 35 in Q1 2023.
- Funds reported $4.25M of Applied Molecular Transport Inc. Common Stock stock for Q2 2023, down 34% quarter-over-quarter.
- 0 funds opened new Applied Molecular Transport Inc. Common Stock positions in Q2 2023 and 7 closed out, a net change of -7 holders.
- The largest Applied Molecular Transport Inc. Common Stock buyer in Q2 2023 was Renaissance Technologies, an estimated $1.13K added.
- The largest Applied Molecular Transport Inc. Common Stock seller in Q2 2023 was Morgan Stanley, an estimated $121K sold.
Based on aggregated 13F filings for Q2 2023.